Literature DB >> 12508244

High-resolution genomic profiling of occult micrometastatic tumor cells.

Jürgen Kraus1, Klaus Pantel, Daniel Pinkel, Donna G Albertson, Michael R Speicher.   

Abstract

Metastasis is responsible for most deaths from cancer. Currently, little is known about the early genetic events in the metastatic evolution. Here we describe the application of a newly developed strategy for an in-depth characterization of genomic changes in micrometastatic cells. Unique tumor cell lines were established from bone marrow of patients with cancer of the prostate and analyzed by multiplex-FISH (M-FISH) and array CGH. M-FISH revealed that the occult disseminated cells were characterized by very complex numerical and structural aberrations. Many of these aberrations resulted in chromosomal gains and losses, such as losses of 8p, 13q, and 18q and gains of 8q, 9q, 20, and the X chromosome, which are typically observed in prostate cancer. Array CGH allowed an unprecedented high-resolution assessment of copy number changes, pinpointing commonly gained or lost regions, which should narrow down the identification of regions critically involved in metastasis. Thus, occult micrometastatic cells are now amenable to detailed analyses of their genome. Markers for prognosis and treatment decisions can now be established. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12508244     DOI: 10.1002/gcc.10160

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  14 in total

1.  A rare-cell detector for cancer.

Authors:  Robert T Krivacic; Andras Ladanyi; Douglas N Curry; H B Hsieh; Peter Kuhn; Danielle E Bergsrud; Jane F Kepros; Todd Barbera; Michael Y Ho; Lan Bo Chen; Richard A Lerner; Richard H Bruce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

2.  Genomic alterations indicate tumor origin and varied metastatic potential of disseminated cells from prostate cancer patients.

Authors:  Ilona N Holcomb; Douglas I Grove; Martin Kinnunen; Cynthia L Friedman; Ian S Gallaher; Todd M Morgan; Cassandra L Sather; Jeffrey J Delrow; Peter S Nelson; Paul H Lange; William J Ellis; Lawrence D True; Janet M Young; Li Hsu; Barbara J Trask; Robert L Vessella
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

3.  Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features.

Authors:  C Shaw-Smith; R Redon; L Rickman; M Rio; L Willatt; H Fiegler; H Firth; D Sanlaville; R Winter; L Colleaux; M Bobrow; N P Carter
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

4.  Genome abnormalities precede prostate cancer and predict clinical relapse.

Authors:  Yan P Yu; Chi Song; George Tseng; Bao Guo Ren; William LaFramboise; George Michalopoulos; Joel Nelson; Jian-Hua Luo
Journal:  Am J Pathol       Date:  2012-05-07       Impact factor: 4.307

Review 5.  Circulating tumor cells and DNA as liquid biopsies.

Authors:  Ellen Heitzer; Martina Auer; Peter Ulz; Jochen B Geigl; Michael R Speicher
Journal:  Genome Med       Date:  2013-08-23       Impact factor: 11.117

6.  Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients.

Authors:  Zhian Liu; Alberto Fusi; Eva Klopocki; Alexander Schmittel; Ingeborg Tinhofer; Anika Nonnenmacher; Ulrich Keilholz
Journal:  J Transl Med       Date:  2011-05-19       Impact factor: 5.531

7.  Rapid detection of genomic imbalances using micro-arrays consisting of pooled BACs covering all human chromosome arms.

Authors:  Jeroen Knijnenburg; Marja van der Burg; Philomeen Nilsson; Hans Kristian Ploos van Amstel; Hans Tanke; Károly Szuhai
Journal:  Nucleic Acids Res       Date:  2005-10-12       Impact factor: 16.971

8.  Genomic Copy Number Variations in the Genomes of Leukocytes Predict Prostate Cancer Clinical Outcomes.

Authors:  Yan P Yu; Silvia Liu; Zhiguang Huo; Amantha Martin; Joel B Nelson; George C Tseng; Jian-Hua Luo
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

9.  Inheritance of gene density-related higher order chromatin arrangements in normal and tumor cell nuclei.

Authors:  Marion Cremer; Katrin Küpper; Babett Wagler; Leah Wizelman; Johann von Hase; Yanina Weiland; Ludwika Kreja; Joachim Diebold; Michael R Speicher; Thomas Cremer
Journal:  J Cell Biol       Date:  2003-09-01       Impact factor: 10.539

Review 10.  Genetic alteration and gene expression modulation during cancer progression.

Authors:  Cathie Garnis; Timon P H Buys; Wan L Lam
Journal:  Mol Cancer       Date:  2004-03-22       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.